Infection of human fetal cardiac myocytes by a human immunodeficiency virus-1-derived vector

Circulation Research

Volumn 83, Issue 7, 1998, Pages 738-742

  Rebolledo, Michael A ^a,b   Krogstad, Paul ^a   Chen, Fuhua ^a   Shannon, Kevin M ^a   Klitzner, Thomas S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

Cardiomyopathy; Cell culture; Fetal heart; Gene therapy; Human immunodeficiency virus

Indexed keywords

ANTIGEN P24; MYOSIN; PHYTOHEMAGGLUTININ; VIRUS DNA; VIRUS PROTEIN; VIRUS VECTOR;

ARTICLE; CARDIOMYOPATHY; CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; FETUS; FETUS CELL; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; LENTIVIRINAE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS;

EID: 0032487336     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.7.738     Document Type: Article

References (35)

1. Herskowitz A. Cardiomyopathy and other symptomatic heart diseases associated with HIV infection. Curr Opin Cardiol. 1996;11:325-331.
2. Michaels AD, Lederman RJ, MacGregor JS, Cheitlin MD. Cardiovascular involvement in AIDS. Curr Probl Cardiol. 1997;22:109-148.
3. Kaplan S, Lipshultz SE. Cardiovascular complications of HIV infection in children. Cardiol Rev. 1995;3:99-105.
4. Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, Lai WW, Moodie DS, McIntosh K, Schluchter MD, Colan SD, Group for the Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Left ventricular structure and function in children infected with human immunodeficiency virus. Circulation. 1998;97:1246-1256.
5. Herskowitz A, Willoughby S, Wu TC, Beschomer WE, Neumann DA, Rose NR, Baughmann KL, Ansari AA. Immunopathogenesis of HIV-1-associated cardiomyopathy. Clin Immunol Immunopathol. 1993;68: 234-241.
6. Herskowitz A, Wu T-C, Willoughby SB, Vlahov DA, Ansari AA, Beschorner WE, Baughmann KL. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late stage infection with human immunodeficiency virus. J Am Coll Cardiol. 1994; 24:1025-1032.
7. Herskowitz A, Willoughby SB, Vlahov D, Baughmann KL, Ansari AA. Dilated heart muscle disease associated with HIV infection. Eur Heart J. 1995;16(suppl O):50-55.
8. Mehta PM, Grainger TA, Lust RM, Movahed A, Terry J, Gilliland MGF, Jolly SR. Effect of cocaine on left ventricular function: relation to wall stress and persistence after treatment. Circulation. 1995;91:3002-3009.
9. Grody WW, Cheng L, Lewis W. Infection of the heart by the human immunodeficiency virus. Am J Cardiol. 1990;66:203-206.
10. Lipshultz SE, Fox CH, Perez-Atayde AR, Sanders SP, Colan SD, McIntosh K, Winter HS. Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol. 1990;66:246-250.
11. Kovacs A, Hinton DR, Wright D, Xu J, Li XL, Rasheed S, Hofman F. Human immunodeficiency virus type 1 infection of the heart in 3 infants with acquired immunodeficiency syndrome and sudden death. Pediatr Infect Dis J. 1996;15:819-824.
12. Rodriguez ER, Nasim S, Hsia J, Sandin RL, Ferreira A, Hilliard BA, Ross AM, Garrett CT. Cardiac myocytes and dendritic cells harbor human immunodeficiency virus in infected patients with and without cardiac dysfunction: detection by mutiplex, nested, polymerase chain reaction in individually microdissected cells from right ventricular endomyocardial biopsy tissue. Am J Cardiol. 1991;68:1511-1520.
13. Lipton SA, Gendelman HE. Seminars in medicine of the Beth Israel Hospital Boston: dementia associated with the acquired immunodeficiency syndrome [see comments]. N Engl J Med. 1995;332:934-940.
14. Ikeuchi K, Kim S, Byrn RA, Goldring SR, Groopman JE. Infection of nonlymphoid cells by human immunodeficiency virus type 1 or type 2. J Virol. 1990;64:4226-4231.
15. Tan X, Pearce-Pratt R, Phillips DM. Productive infection of a cervical epithelial cell line with human immunodeficiency virus: implications for sexual transmission. J Virol. 1993;67:6447-6452.
16. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 1993;57:183-289.
17. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986;59:284-291.
18. Planelles V, Haislip A, Withers-Ward ES, Stewart SA, Xie Y, Shah NP, Chen IS. A new reporter system for detection of retroviral infection. Gene Ther. 1995;2:369-376.
19. Tornatore C, Nath A, Amemiya K, Major EO. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol. 1991;65:6094-6100.
20. Shannon KM, Klitzner TS, Chen F, Van Dop C. Effects of triiodothyronine on retention of ß-adrenergic responsiveness of voltage-gated transmembrane calcium current during culture of ventricular myocytes from neonatal rabbits. Pediatr Res. 1994;37:277-282.
21. Zack JA, Haislip AM, Krogstad P, Chen IS. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J Virol. 1992;66:1717-1725.
22. Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC, Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A. 1994;91:9564-9568.
23. An DS, Koyanagi Y, Zhao JQ, Akkina R, Bristol G, Yamamoto N, Zack JA, Chen IS. High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells. J Virol. 1997;71:1397-1404.
24. Yee JK, Friedmann T, Burns JC. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 1994; 43:99-112.
25. Peden KWC, Martin MA. Virological and molecular genetic techniques for studies of established HIV isolates. In: Karn J, ed. HIV: A Practical Approach. 1st ed. New York, NY: IRL Press at Oxford University Press; 1995:25-26.
26. Zack JA, Arrigo SJ, Weitsman SR. Go AS, Haislip A, Chen IS. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell. 1990;61:213-222.
27. Abbot MA, Poiesz BJ, Byrne BC, Kwok S, Sninsky JJ, Ehrlich GD. Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J Infect Dis. 1988;158: 1158-1169.
28. 2+ exchange protein in developing rabbit myocytes. Am J Physiol. 1995;268:C1126-C1132.
29. Cho MC, Koch WJ, Rockman H. Gene therapy for chronic heart failure. ACC Curr J Rev. 1997;6:56-58.
30. Towbin JA, Roberts RR, Caskey CT. Molecular genetics of the cardiovascular system. In: Garson A Jr, Bricker JT, McNamara DG. eds. The Science and Practice of Pediatric Cardiology. Philadelphia, PA: Lea & Febiger; 1990:3-70.
31. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272:263-267.
32. Vodicka MA, Koepp DM, Silver PA, Emerman M. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 1997;12:175-185.
33. Verma IM, Somia N. Gene therapy-promises, problems, and prospects. Nature. 1997;389:239-242.
34. Levi M, Coronel R. Gene therapy in the cardiovascular system. Cardiovasc Res. 1997;35:389-390.
35. Leor J, Prentice H, Sartorelli V, Quinones MJ, Patterson M, Kedes LK, Kloner RA. Gene transfer and cell transplant: an experimental approach to repair a "broken heart." Cardiovasc Res. 1997;35:431-441.